Sector revisions VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2025-01-17 pm EST 5-day change 1st Jan Change
2.700 USD +4.65% Intraday chart for VYNE Therapeutics Inc. -10.60% -19.40%
Main competitors
Add to a list
1m. EPS revision 1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Divergence of Estimates Nbr of analysts
- 4
30
25
16
20
23
17
24
- - - - - - 7
16
16
21
- - - 9
22
25
- - - -
15
5
11
18
Average 17
Weighted average by Cap. 22
Bio Therapeutic Drugs